Clinical Trial

Tibial Nerve Elastography in Chemotherapy-Induced Neuropathic Pain

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 2, 2025 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study aims to evaluate the tibial nerve stiffness using Shear Wave Elastography (SWE) in patients with chemotherapy-induced peripheral neuropathy (CIPN) compared to healthy volunteers. A total of 25 patients with a DN4 score ≥4 and 25 healthy controls will be assessed. Parameters including nerve diameter, cross-sectional area, depth, and shear wave velocity (V value) will be measured. Demographic and clinical data such as age, gender, chemotherapy protocol, duration, comorbidities, and medications will also be collected. The goal is to investigate SWE as a non-invasive diagnostic tool for CIPN by identifying differences in nerve elasticity between groups.
Trial Details
NCT Number NCT07048431
Lead Sponsor Ankara Etlik City Hospital
Conditions Chemotherapy-induced Peripheral Neuropathy, Tibial Neuropathy
Enrollment 50 participants
Start Date 2025-09-15
Primary Completion 2025-10-15 (estimated)
Study Completion 2025-11-15 (estimated)
Updated on ClinicalTrials.gov 2025-07-02